David Muldoon

Manus appoints David Muldoon as Chief Business Officer

Press Release

12:30 p.m. EDT. June 21, 2024

Media Relations Contact

Frederik Bjoerndal, Vice President
Corporate Affairs and Marketing Communications


Accomplished biotech senior executive brings purpose, commitment, and unwavering drive for accelerating the transition to bioalternatives.

David Muldoon

Ajikumar Parayil

BOSTON, United States – June 21, 2024 – Manus, the world’s leading bioalternatives scale-up platform, has hired industry veteran David Muldoon, who joins the growing company this month as its new Chief Business Officer (CBO).

David Muldoon is an accomplished senior executive with more than 25 years of deep industry and value chain experience in sustainable chemistry, materials, and biotechnology. He joins Manus from industrial biotech company Geno, where he was Chief Operating Officer and has an impressive track record as an inspiring and strategic business leader at BASF and Ciba.

“We are delighted that David will join our Senior Leadership Team,” says Ajikumar Parayil, Founder and Chief Executive Officer of Manus. “With extensive experience in sustainable biotechnology, David will contribute significantly to our business strategy and help drive Manus forward in meeting the significant challenges of scaling biotech for the chemical, ingredients, and materials value chain.”

Muldoon’s key responsibilities will include the development and implementation of a five-year strategic plan. He will lead the areas of Commercial and Business Development.

“I am honored to join Manus, who is well-positioned to take on the challenges of bringing bioalternatives to market at scale,” says David Muldoon. "Its unique set of capabilities, including industry-leading cell factory engineering, advanced piloting capabilities, and commercial scale production, sets it apart in the industry. I look forward to helping Manus unlock this unique value and accelerate the growth of bioalternatives, bringing a positive impact to people and the environment."    

Manufacturing many of today’s everyday products is resource intensive and comes with a heavy environmental cost. Through its BioAccelerator and Biomanufacturing Programs, Manus enables companies across industries to replace existing ingredients, materials, and chemicals with bioalternatives, increasing supply security while reducing environmental impacts.

“David brings purpose, commitment, and an unwavering drive to the table that will challenge the status quo, and we are very excited about the future for Manus with him onboard,” finishes Ajikumar Parayil.

Share this article: